Skip to main content
OpenTrials
Completed

NCT Number: NCT02444845

Study of Anemia in Chronic Kidney Disease (CKD) Among High-Risk Hypertensive and Diabetic Patients in Pakistan

The purpose of this study is to evaluate the prevalence of CKD-related anemia at an early stage through screening of high-risk patients in Pakistan at the level of physicians, cardiologists, and diabetologists. The information gathered may serve as a foundation in formulating national guidelines for better early diagnosis and management of patients with CKD.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age greater than or equal to 40 years
  • Known hypertension and/or diabetes for at least 3 years
  • Positive dipstick test result for proteinuria

Exclusion criteria

  • Known CKD
  • Receiving erythropoietin
  • Blood transfusion within 8 weeks
  • History of acute or chronic bleeding, hemolysis, or hemoglobinopathy

Treatment and study plan

Primary outcomes

  1. Number of patients with anemia secondary to CKD

    Time frame: Up to 12 months

Secondary outcomes

  1. Use of treatment modalities for the management of anemia secondary to CKD

    Time frame: Up to 12 months

Sponsors and collaborators

Lead sponsor

Hoffmann-La Roche

Industry

Registry information

Official study title

Prevalence of Anaemia Secondary to Early Stage Chronic Kidney Disease in High Risk Diabetic and/or Hypertensive Population

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
May 15, 2015
Registry last updated
Mar 20, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.